XML 16 R9.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 98,896 $ 64,197
Adjustments to reconcile net income from operations to net cash provided by operating activities:    
Depreciation 25,523 23,354
Stock-based compensation 15,204 15,758
Equity in net earnings of affiliate 5,584 0
Provision for excess and obsolete inventory 4,945 6,177
Amortization 4,779 4,766
Losses (gains) on investments 3,372 10,466
Deferred taxes (7,811) (9,669)
Other 3,483 787
Changes in operating assets and liabilities, net of businesses acquired:    
Accounts receivable 13,053 (8,055)
Inventories (31,049) (6,932)
Prepayments and other assets 13,650 11,089
Accounts payable and other liabilities (9,950) (105,548)
Deferred revenue and customer advances 10,200 (1,444)
Retirement plans contributions (1,282) (1,421)
Income taxes 13,040 3,754
Net cash provided by operating activities 161,637 7,279
Cash flows from investing activities:    
Purchases of property, plant and equipment (64,021) (44,023)
Acquisition of businesses, net of cash acquired (17,002) 0
Investments in businesses (3,011) 0
Purchases of marketable securities (10,753) (16,042)
Proceeds from maturities of marketable securities 27,381 14,438
Proceeds from sales of marketable securities 5,633 20,734
Proceeds from life insurance 0 873
Net cash used for investing activities (61,773) (24,020)
Cash flows from financing activities:    
Repurchase of common stock (157,475) (22,117)
Dividend payments (19,406) (18,370)
Payments related to net settlement of employee stock compensation awards (14,726) (13,115)
Issuance of common stock under stock purchase and stock option plans 14,792 16,934
Net cash used for financing activities (176,815) (36,668)
Effects of exchange rate changes on cash and cash equivalents (771) 3,241
Decrease in cash and cash equivalents (77,722) (50,168)
Cash and cash equivalents at beginning of period 553,354 757,571
Cash and cash equivalents at end of period 475,632 707,403
Non-cash investing activities:    
Capital expenditures incurred but not yet paid: $ 7,135 $ 3,086